microdosing glp 1 perimenopause GLP-1 for Perimenopause: Why Lower Doses Might Be Better Microdosing GLP‑1 in Menopause &
Description
Following treatment withdrawal, semaglutide participant's regained two-thirds of their prior weight reduction, with net losses of 5.6 % at week 120 compared to baseline with similar changes in cardiometabolic variables (lipid levels, glycemic control, blood pressure and inflammatory markers) [171]
So we always do post-intervention surveys to look for these types of things
Accept the partial dose and continue your regular schedule
What exactly is microdosing
